| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | Aug 28, 2025 | CATALYST PHARMACEUTICALS, INC. | CEO | Sell | 40.0 | -22,970 | -9.20% | ✗ | $473.6K |
| May 30, 2025 | Jun 3, 2025 | CATALYST PHARMACEUTICALS, INC. | CEO | Buy | 100.0 | +70,000 | 53.94% | ✗ | $1.7M |
| Jun 4, 2024 | Jun 5, 2024 | CATALYST PHARMACEUTICALS, INC. | CEO | Sell | 40.0 | -17,323 | -6.87% | ✗ | $276.7K |
| May 17, 2017 | May 18, 2017 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +7,500 | 47.43% | ✗ | $30K |
| Feb 24, 2017 | Feb 27, 2017 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +2,591 | 19.60% | ✗ | $10K |
| Jan 25, 2017 | Jan 27, 2017 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +2,841 | 27.37% | ✗ | $10K |
| Dec 23, 2016 | Dec 30, 2016 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +32,259 | 31.42% | ✗ | $10K |
| Nov 25, 2016 | Nov 28, 2016 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +35,715 | 53.33% | ✗ | $10K |
| Oct 25, 2016 | Oct 27, 2016 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +35,715 | 114.29% | ✗ | $10K |
| Sep 23, 2016 | Sep 26, 2016 | PALISADE BIO, INC. | CEO | Buy | 91.3 | +31,250 | 100.00% | ✗ | $10K |